Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Schmelcher

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2014
Use of bacteriophage cell wall-binding proteins for rapid diagnostics of ListeriaMathias Schmelcher, Martin J Loessner
Bacteriophage|February 18, 2014
Application of bacteriophages for detection of foodborne pathogensMathias Schmelcher, Martin J Loessner
Current Opinion in Biotechnology|December 29, 2015
Bacteriophage endolysins: applications for food safetyMathias Schmelcher, Martin J Loessner
Current Opinion in Biotechnology|October 30, 2020
Bacteriophage endolysins - extending their application to tissues and the bloodstreamMathias Schmelcher, Martin J Loessner
Applied Microbiology and Biotechnology|July 2, 2011
Listeria bacteriophage peptidoglycan hydrolases feature high thermoresistance and reveal increased activity after divalent metal cation substitutionMathias Schmelcher, Florian Waldherr, Martin J Loessner
Future Microbiology|October 4, 2012
Bacteriophage endolysins as novel antimicrobialsMathias Schmelcher, David M Donovan, Martin J Loessner
Microbial Biotechnology|May 4, 2011
Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinityMathias Schmelcher, Vincent S Tchang, Martin J Loessner
Viruses|November 16, 2018
Ultrasensitive and Fast Diagnostics of Viable <i>Listeria</i> Cells by CBD Magnetic Separation Combined with A511::<i>luxAB</i> DetectionJan W Kretzer, Mathias Schmelcher, Martin J Loessner
Computational and Structural Biotechnology Journal|January 11, 2021
Deimmunization of protein therapeutics - Recent advances in experimental and computational epitope prediction and deletionLéa V Zinsli, Noël Stierlin, Martin J Loessner, et al.
Clinical Microbiology Reviews|December 1, 2017
Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery StrategiesHamed Haddad Kashani, Mathias Schmelcher, Hamed Sabzalipoor, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2014
Use of bacteriophage cell wall-binding proteins for rapid diagnostics of ListeriaMathias Schmelcher, Martin J Loessner
Bacteriophage|February 18, 2014
Application of bacteriophages for detection of foodborne pathogensMathias Schmelcher, Martin J Loessner
Current Opinion in Biotechnology|December 29, 2015
Bacteriophage endolysins: applications for food safetyMathias Schmelcher, Martin J Loessner
Current Opinion in Biotechnology|October 30, 2020
Bacteriophage endolysins - extending their application to tissues and the bloodstreamMathias Schmelcher, Martin J Loessner
Applied Microbiology and Biotechnology|July 2, 2011
Listeria bacteriophage peptidoglycan hydrolases feature high thermoresistance and reveal increased activity after divalent metal cation substitutionMathias Schmelcher, Florian Waldherr, Martin J Loessner
Future Microbiology|October 4, 2012
Bacteriophage endolysins as novel antimicrobialsMathias Schmelcher, David M Donovan, Martin J Loessner
Microbial Biotechnology|May 4, 2011
Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinityMathias Schmelcher, Vincent S Tchang, Martin J Loessner
Viruses|November 16, 2018
Ultrasensitive and Fast Diagnostics of Viable <i>Listeria</i> Cells by CBD Magnetic Separation Combined with A511::<i>luxAB</i> DetectionJan W Kretzer, Mathias Schmelcher, Martin J Loessner
Computational and Structural Biotechnology Journal|January 11, 2021
Deimmunization of protein therapeutics - Recent advances in experimental and computational epitope prediction and deletionLéa V Zinsli, Noël Stierlin, Martin J Loessner, et al.
Clinical Microbiology Reviews|December 1, 2017
Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery StrategiesHamed Haddad Kashani, Mathias Schmelcher, Hamed Sabzalipoor, et al.
Pageof 5